Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) — The “UAE Genetic Testing Market, By Region, Competition, Forecast and Opportunities, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The UAE Genetic Testing Market was valued at USD 39.11 Million in 2024, and is expected to reach USD 118.43 Million by 2030, rising at a CAGR of 20.28%.
Genetic testing is a medical test that examines an individual’s DNA, the genetic material that carries the instructions for the development, functioning, and maintenance of living organisms. The primary goal of genetic testing is to identify changes or variations in a person’s genes that may be associated with a specific condition or the risk of developing a particular disease. DNA (deoxyribonucleic acid) is a hereditary material found in nearly all cells of the body.
It contains genes, which are segments of DNA that provide instructions for the synthesis of proteins and the regulation of various cellular functions. Genetic testing results are typically provided as a report indicating whether specific genetic variations were identified. The interpretation of results may involve the identification of disease risk, confirmation of a diagnosis, or information about carrier status. Genetic counseling is often recommended before and after genetic testing. Genetic counselors provide information about the test, help individuals understand the implications of the results, and assist in decision-making.
The prevalence of genetic disorders in the population can drive the demand for genetic testing. As awareness of these disorders increases, individuals and healthcare providers may seek genetic testing for early diagnosis and intervention. Continuous advancements in genetic testing technologies, such as next-generation sequencing, enhance the accuracy, efficiency, and affordability of testing. Technological progress is a significant driver of market expansion. Genetic testing during pregnancy (prenatal testing) and in newborns (neonatal testing) is a common practice.
Advances in prenatal screening and diagnostic technologies contribute to the growth of genetic testing services for expectant parents. Direct-to-consumer genetic testing services that offer insights into ancestry and heritage have gained popularity. Consumer interest in understanding genetic origins contributes to the overall growth of the genetic testing market. Integration of genetic testing into routine healthcare practices and guidelines can drive adoption. As healthcare professionals become more familiar with the clinical utility of genetic information, testing becomes a standard part of patient care.
Key Market Drivers
Prevalence of Genetic Disorders
Genetic testing allows for the early detection of genetic disorders or the identification of individuals at risk. Early detection can enable timely interventions and medical management, potentially improving outcomes and quality of life for affected individuals. According to UAE government data, approximately 75 of every 1,000 newborns in the country are diagnosed with a congenital disability, with the majority attributed to genetic factors.
Genetic testing provides individuals and families with valuable information about their genetic makeup and potential risks for certain disorders. This information empowers them to make informed decisions about family planning, treatment options, and preventive measures. Many genetic disorders are hereditary, meaning they can be passed down from one generation to the next. Families with a history of genetic disorders may seek genetic testing to assess the risk of passing on these conditions to their children.
Genetic testing allows for risk assessment, which is particularly important for conditions with a genetic component, such as certain types of cancer. Individuals with an elevated genetic risk can take proactive measures for prevention, including increased surveillance or preventive surgeries. Genetic testing is routinely used in prenatal and neonatal screening to identify genetic abnormalities in developing fetuses or newborns. This information can guide medical care and treatment plans for affected infants.
Genetic testing is crucial for the diagnosis of rare genetic diseases. As these conditions often have a genetic basis, genetic testing plays a pivotal role in identifying the specific genetic mutations responsible for the disorders. The growing emphasis on precision medicine, which tailors’ medical treatment to an individual’s genetic makeup, relies heavily on genetic testing. Understanding a patient’s genetic profile allows healthcare providers to prescribe personalized and targeted therapies.
In some cases, governments or healthcare systems implement population screening programs to identify individuals at risk for certain genetic conditions. This can contribute to a broader adoption of genetic testing. As awareness of the genetic basis of diseases grows, more individuals and healthcare providers recognize the value of genetic testing. This increased awareness contributes to the overall demand for genetic testing services. The availability of genetic counseling services, often integrated with genetic testing programs, helps individuals interpret their test results and understand the implications for their health and the health of their families. This factor will help in the development of the UAE Genetic Testing Market.
Key Market Challenges
Ethical Considerations
Ensuring that individuals undergoing genetic testing provide informed consent is crucial. This includes clearly communicating the purpose, potential risks, benefits, and limitations of the testing. Genetic information is highly sensitive. Maintaining the privacy and security of individuals’ genetic data is paramount to prevent unauthorized access, misuse, or potential discrimination based on genetic information. Concerns about genetic discrimination in areas such as employment and insurance may arise. Striking a balance between the right to know one’s genetic information and protecting individuals from discrimination based on that information is an ethical challenge.
Considering the cultural and religious beliefs of the diverse population in the UAE is crucial. Some communities may have specific views on genetic testing, and ethical practices should respect and accommodate these perspectives. Ensuring equitable access to genetic testing services is essential. Ethical concerns arise if certain segments of the population, especially vulnerable or marginalized groups, do not have equal access to these services. Providing adequate genetic counseling services is essential for helping individuals understand the implications of their genetic test results. Ensuring that individuals receive proper counseling before and after testing is an ethical imperative.
Key Market Trends
Increased Demand for Non-Invasive Prenatal Testing (NIPT)
NIPT offers high accuracy in detecting common chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), among others. Early detection during the first trimester provides expectant parents with more time to make informed decisions about their pregnancy. NIPT is a non-invasive procedure that only requires a blood sample from the pregnant woman. This reduces the risk compared to invasive procedures like amniocentesis or chorionic villus sampling (CVS). Increased awareness among pregnant women and healthcare providers about the availability and benefits of NIPT contributes to its rising demand.
Educational campaigns and information dissemination may play a role in promoting the adoption of NIPT. Advanced maternal age is associated with an increased risk of chromosomal abnormalities. As maternal age trends upward, there is a growing interest in early and accurate prenatal screening. There is increased insurance coverage or affordability of NIPT, it can drive demand by making the testing more accessible to a broader range of expectant parents. Many expectant parents may prefer non-invasive testing methods to avoid the potential risks associated with invasive procedures, even if they have lower associated risks.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $39.11 Million |
| Forecasted Market Value (USD) by 2030 | $118.43 Million |
| Compound Annual Growth Rate | 20.2% |
| Regions Covered | United Arab Emirates |
Report Scope:
Key Market Players
- Freiburg Medical Laboratory Middle East LLC
- Fakih IVF Center
- Beyond Nutrition Health and Wellness Services DMCC
- Genesis Healthcare Center
- Dante Labs
- Reem Medical Group
UAE Genetic Testing Market, By Type:
- Carrier Testing
- Diagnostic Testing
- New-born Screening
- Predictive & Presymptomatic Testing
- Prenatal Testing
- Others
UAE Genetic Testing Market, By Disease:
- Sickle Cell Anemia
- Thalassemia
- Huntington’s Disease
- Cancer
- Others
UAE Genetic Testing Market, By Technology:
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
UAE Genetic Testing Market, By Service Providers:
- Clinical & Metabolic Specialists
- Genetic Counsellors
- Diagnostic Laboratories
- Hospitals
UAE Genetic Testing Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
- Rest of UAE
For more information about this report visit https://www.researchandmarkets.com/r/nh0mnb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- UAE Genetic Testing Market
